SCHEMBL6909319

SCHEMBL6909319

CC(=O)Nc1cccc2cc(S(=O)(=O)NCc3c(F)cccc3F)ccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.61
CYP19A1 P11511 2/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 4/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 3/20 0.40
PKM P14618 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
KAT6A Q92794 1/20 0.40
LMNA P02545 1/20 0.40
FGF1 P05230 1/20 0.40
MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6909638 0.86 CASP6 (0.58) CASP6CYP19A1ALDH1A1MAPTKDM4E
SCHEMBL4483879 0.84 CASP6 (0.64) CASP6CYP19A1CA9MAPTKDM4E
SCHEMBL6907200 0.82 CASP6 (0.61) CASP6CYP19A1CA9ALDH1A1MAPT
SCHEMBL6906323 0.81 CASP6 (0.60) CASP6CYP19A1ALDH1A1HPGDKMT2A
SCHEMBL6906511 0.81 CASP6 (0.59) CASP6CYP19A1ALDH1A1MAPTKMT2A
SCHEMBL4480386 0.80 CASP6 (0.58) CASP6CYP19A1ALDH1A1MAPTHPGD
SCHEMBL6903974 0.80 ATM (0.64) CASP6RAB9APOLB
SCHEMBL4556308 0.80 CASP6 (0.58) CASP6CYP19A1ALDH1A1MAPTHPGD
SCHEMBL4450789 0.79 EDNRA (0.49) KMT2A
SCHEMBL4479011 0.77 CASP6 (0.55) CASP6MAPTKMT2ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040234622-A1 Sulfonamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040234622-A1 Sulfonamide derivatives PCNA, TOP2A, DDB1 CASP6 334/4885CYP19A1 976/4885CA1 2328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.